Market Research Logo

Biocept Inc (BIOC) - Product Pipeline Analysis, 2018 Update

Summary

Biocept Inc (Biocept) is a molecular diagnostics company. The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood sample. It offers assays for solid tumor indications, such as breast cancer, non-small cell lung cancer, small cell lung cancer, gastric cancer, colorectal cancer, prostate cancer, melanoma, pancreatic biliary cancer, and ovarian cancer. Biocept offers related instrumentation, OncoCEE technology, and analytical capabilities for rare event detection and genetic characterization. The company’s OncoCEE platform modifies rare cell capture and analyses methods. It serves cancer diagnostic assays to oncologists and other physicians; hospitals, and cancer centers. Biocept also provides clinical trial and research services to pharmaceutical and biopharmaceutical companies; and clinical research organizations. Biocept is headquartered in San Diego, California, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Biocept Inc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company


Biocept Inc Company Overview
Biocept Inc Company Snapshot 5
Biocept Inc Pipeline Products and Ongoing Clinical Trials Overview
Biocept Inc – Pipeline Analysis Overview 7
Biocept Inc - Key Facts 7
Biocept Inc - Major Products and Services 8
Biocept Inc Pipeline Products by Development Stage 9
Biocept Inc Ongoing Clinical Trials by Trial Status 11
Biocept Inc Pipeline Products Overview 13
Companion Diagnostic Target Selector Test - SCLC 13
Companion Diagnostic Target Selector Test - SCLC Product Overview 13
MicroRNA Test - Lung Cancer 14
MicroRNA Test - Lung Cancer Product Overview 14
OncoCEE - CR (FISH) 15
OncoCEE - CR (FISH) Product Overview 15
preCEED 16
preCEED Product Overview 16
Target Selector CTC Test - EGFR Amplification 17
Target Selector CTC Test - EGFR Amplification Product Overview 17
Target Selector CTC Test - ESR1 18
Target Selector CTC Test - ESR1 Product Overview 18
Target Selector CTC Test - ESR1 Clinical Trial 19
Target Selector CTC Test - PTEN Deletion 20
Target Selector CTC Test - PTEN Deletion Product Overview 20
Target Selector ctDNA Test - ALK 21
Target Selector ctDNA Test - ALK Product Overview 21
Target Selector ctDNA Test - ALK Clinical Trial 22
Target Selector ctDNA Test - ESR1 23
Target Selector ctDNA Test - ESR1 Product Overview 23
Biocept Inc - Key Competitors 24
Biocept Inc - Key Employees 25
Biocept Inc - Locations And Subsidiaries 26
Head Office 26
Recent Developments 27
Biocept Inc, Recent Developments 27
Jul 17, 2018: Alliance Global to market Biocept liquid biopsy tests 27
Jun 18, 2018: Published Case Report Demonstrates the Clinical Utility of Biocept''''s CTC Platform in the Management of Patients with Metastatic Breast Cancer 27
Jun 11, 2018: VWR and Biocept Announce the Launch of CEE-Sure Blood Collection Tubes for cfDNA and CTCs 28
May 15, 2018: Biocept Announces First Quarter 2018 Financial Results 28
May 01, 2018: Case Report in Journal of Thoracic Oncology Demonstrates the Clinical Utility of Biocept''s Liquid Biopsy Test for Patient Diagnosed with Non-Small Cell Lung Cancer 30
Apr 27, 2018: Published Case Study Demonstrates the Clinical Utility of Biocept''s Liquid Biopsy Test for ALK Rearrangements 30
Mar 28, 2018: Biocept and Thermo Fisher Scientific Enter into Technology and Commercial Collaboration 31
Mar 28, 2018: Biocept Reports 2017 Fourth Quarter and Full Year Financial Results 31
Mar 20, 2018: Biocept to Present Recent Advances in Biomarker Identification from Liquid Biopsies at GTCbio's 11th Biomarker Summit 34
Mar 15, 2018: Biocept's Target Selector Platform Featured in Two Poster Presentations at the 2018 American Association for Cancer Research Annual Meeting 34
Appendix 36
Methodology 36
About GlobalData 39
Contact Us 39
Disclaimer 39
List of Tables
Biocept Inc Pipeline Products and Ongoing Clinical Trials Overview 5
Biocept Inc Pipeline Products by Equipment Type 6
Biocept Inc Pipeline Products by Indication 6
Biocept Inc Ongoing Clinical Trials by Trial Status 6
Biocept Inc, Key Facts 7
Biocept Inc, Major Products and Services 8
Biocept Inc Number of Pipeline Products by Development Stage 9
Biocept Inc Pipeline Products Summary by Development Stage 10
Biocept Inc Ongoing Clinical Trials by Trial Status 11
Biocept Inc Ongoing Clinical Trials Summary 12
Companion Diagnostic Target Selector Test - SCLC - Product Status 13
Companion Diagnostic Target Selector Test - SCLC - Product Description 13
MicroRNA Test - Lung Cancer - Product Status 14
MicroRNA Test - Lung Cancer - Product Description 14
OncoCEE - CR (FISH) - Product Status 15
OncoCEE - CR (FISH) - Product Description 15
preCEED - Product Status 16
preCEED - Product Description 16
Target Selector CTC Test - EGFR Amplification - Product Status 17
Target Selector CTC Test - EGFR Amplification - Product Description 17
Target Selector CTC Test - ESR1 - Product Status 18
Target Selector CTC Test - ESR1 - Product Description 18
Target Selector CTC Test - ESR1 - Biocept's Liquid Biopsy Platform to Evaluate Cerebrospinal Fluid of Breast Cancer Patients for Metastatic Biomarkers 19
Target Selector CTC Test - PTEN Deletion - Product Status 20
Target Selector CTC Test - PTEN Deletion - Product Description 20
Target Selector ctDNA Test - ALK - Product Status 21
Target Selector ctDNA Test - ALK - Product Description 21
Target Selector ctDNA Test - ALK - Evaluation of Liquid Biopsies in Localized and Advanced Lung Cancer Patients 22
Target Selector ctDNA Test - ESR1 - Product Status 23
Target Selector ctDNA Test - ESR1 - Product Description 23
Biocept Inc, Key Employees 25
Glossary 38
List of Figures
Biocept Inc Pipeline Products by Equipment Type 6
Biocept Inc Pipeline Products by Development Stage 9
Biocept Inc Ongoing Clinical Trials by Trial Status 11

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report